Reducing Risk in Estrogen Detoxification Webinar Comments
SPEAKER: Dr. Carrie Jones, ND, MPH
WHEN: 7 PM - 9 PM (EST)
CE CREDITS: BC NDs: 2 Category C. Ontario NDs: CONO-Approved for 2 Category A (1 General; 1 Pharma). Other Canadian NDs: this webinar should be eligible for contining education credits in your jurisdiction, please confirm with your regulator.
Do you understand the 3 phases of estrogen detox? If estrogens takes an unhealthy path or do not go through methylation, they form a quinone that can result in DNA damage and increased cancer risk. Practitioners need to understand estrogen metabolism in-depth, including the genetics involved, the microbiome’s influence and how to optimize enzymes to prevent or reverse quinone formation.
Join internationally-renowned hormone health speaker Dr. Carrie Jones, ND, MPH to discuss a wealth of treatment options to improve phase 1, 2 and 3 detoxification, and reduce estrogen dominance and estrogen-based cancer risk in both men and women. Learn how to improve your patients’ hormone health and reduce treatment risk.
We are grateful to Course Sponsor In-Common Laboratories
Wednesday, 12 June, 2019
Cost:OAND Members: $60. Non-Members: $80
Website: Click to Visit